Leverage Analysis Stories
How much will Herbalife Nutrition owe in October?
![]() | 3 days ago at Macroaxis By Gabriel Shpitalnik |
Herbalife Nutrition, a prominent player in the Personal Care Products industry, has shown some intriguing financial dynamics as we head into October. Despite a significant Retained Earnings loss of 1.2B, the company's Total Revenue stands strong at 5.2B, outpacing the Cost Of Revenue of 1.2B. The company's End Period Cash Flow is also robust at 516.3M, supporting a healthy Free Cash Flow of 196.1M. However, the company's financial health is somewhat marred by a hefty Non Current Liabilities Total of 3B and a Net Tangible Assets deficit of 1.7B. Continue Reading...
- HLF Herbalife Nutrition
- Latest How much will Herbalife Nutrition owe in October
- HLF 14.49 -0.22
- Low 14.31
- High 15.13
- Alpha 0.29
- Beta 1.93
- Return On Asset 0.1
- Profit Margin 0.0448 %
- Operating Margin 0.09 %
- Current Valuation 3.77 B
- Shares Outstanding 99 M
- Shares Owned by Insiders 2.47 %
- Shares Owned by Institutions 97.53 %
- Number of Shares Shorted 12.32 M
- Price to Earning 5.48 X
- Price to Sales 0.24 X
- Revenue 5.2 B
- Gross Profit 2.34 B
- EBITDA 673.4 M
- Net Income 321.3 M
- Cash and Equivalents 508 M
- Cash per Share 5.44 X
- Total Debt 2.88 B
- Debt to Equity 7.30 %
- Current Ratio 1.40 X
- Book Value Per Share (11.63) X
- Cash Flow from Operations 352.5 M
- Short Ratio 7.82 X
- Earnings Per Share 2.31 X
- Price to Earnings To Growth (32.80) X
- Target Price 20.7
- Number of Employees 10.1 K
- Beta 1.19
- Market Capitalization 1.43 B
- Total Asset 2.73 B
- Retained Earnings (1.2 B)
- Working Capital 379.5 M
- Current Asset 1.57 B
- Current Liabilities 1.02 B
- Z Score 2.56
- Net Asset 2.73 B
Macroaxis uses a strict editorial review process to publish stories and blog posts. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Vlad Skutelnik
Independent Bank, a regional bank listed on NASDAQ (USA Stocks: IBCP), has been a subject of discussion among investors due to its potential increase in debt. With net borrowings currently standing at $56M, there is a growing concern about the bank's leverage. However, it's important to note that the bank has a substantial amount of cash and short-term investments, amounting to approximately $853.7M, which could provide a buffer against any potential financial strain. The bank's operating income, which is equivalent to its EBIT, is reported at $97.2M.
few days ago at Macroaxis By Ellen Johnson | ![]() |
As we step into October, investors are keenly observing the potential of Healthcare Triangle, a prominent player in the Healthcare sector listed on NASDAQ. Despite the company's recent financial struggles, with a net loss of 9.6M and an operating income loss of 10.4M, there are several indicators that suggest a possible upside for the stock. The company's total stockholder equity stands at 12.4M, and it has total assets worth 20.8M, demonstrating a solid financial base. Moreover, the company's total cash from financing activities amounts to 5.5M, indicating a robust financial strategy despite the losses.
over a week ago at Macroaxis By Nico Santiago | ![]() |
Charles Schwab Corp currently has $37.88 billion in liabilities, with a Debt to Equity (D/E) ratio of 0.71. This ratio is roughly average when compared to similar companies. The asset utilization indicator is a measure of the revenue generated for every dollar of assets reported by a company. Charles Schwab has an asset utilization ratio of 3.76 percent, which means that the company generates $0.0376 for each dollar of assets.
over a week ago at Macroaxis By Aina Ster | ![]() |
TopBuild Corp carries a debt of $1.68 billion, with a debt-to-equity (D/E) ratio of 0.96. This is considered acceptable within its current industry classification. The company has a performance score of 11 on a scale of 0 to 100. TopBuild Corp's beta is 1.2806, indicating a somewhat significant risk relative to the market.
over a week ago at Macroaxis By Vlad Skutelnik | ![]() |
Rekor Systems, a domestic technology company specializing in software, recently experienced a 6% pullback, presenting a potential buying opportunity for investors. Despite reporting a loss of $50.9M in EBIT and $43.8M in free cash flow, the company has a total stockholder equity of $49.3M and an end period cash flow of $2.5M. With a total revenue of $19.9M against a cost of revenue of $10.9M, and net receivables of $3.6M, the company's financials show potential for growth. Furthermore, the company has made significant investments in research and development, amounting to $18.6M, indicating a commitment to innovation and future growth.
over two weeks ago at Macroaxis By Ellen Johnson | ![]() |
Asana Inc, a notable player in the Technology sector and specifically in the Software service category, has shown significant financial movements in the recent period. The company's end period cash flow increased significantly to 526.6M from a beginning cash flow of 240.4M, indicating a strong cash management strategy. However, Asana Inc reported a substantial loss in EBIT and net income, both standing at 407.8M. This loss is largely attributed to the total operating expenses of 898.5M, which included 166.3M in selling, general, and administrative expenses.
over two weeks ago at Macroaxis By Aina Ster | ![]() |
Investors considering National Bank (CA:NA) should take note of its robust financial health, as evidenced by its significant other cashflows from financing activities, which stands at a substantial 1.2 billion. The bank's total revenue is also noteworthy, reaching 9.6 billion, far surpassing its selling general administrative expense of 3.3 billion. This financial strength is further underscored by the bank's net income applicable to common shares, which is reported at 3.3 billion. However, potential investors should also be aware of the bank's short and long term debt, which is quite high at 17.1 billion.
over three weeks ago at Macroaxis By Gabriel Shpitalnik | ![]() |
Investing in Akebia Therapeutics (NASDAQ: AKBA) stock presents a mixed bag of opportunities and risks. On the positive side, the company has a Potential Upside of 17.24, suggesting that the stock has room for growth. The Jensen Alpha of 0.432 also indicates a potential for higher returns when adjusted for risk. However, the company's financial health paints a less rosy picture.
over three weeks ago at Macroaxis By Ellen Johnson | ![]() |
The company, Smart Share Global, has reported total liabilities of 10.62 million, with a debt to equity ratio (D/E) of 0.05. This might suggest that Smart Share is not fully capitalizing on financial leverage. With a current ratio of 2.74, Smart Share Global demonstrates a strong position to meet its debt obligations on time. Debt can be beneficial for Smart Share, provided it doesn't encounter difficulties in paying it off, either through new capital or free cash flow.
over a month ago at Macroaxis By Aina Ster | ![]() |